- Did you mean
- tla vaccines
Search results - 11 results
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021
(2023) Keywords: Alpha COVID-19 Delta Vaccine effectiveness Health Topics: Acute respiratory tract infection Acute luchtweginfectie Infection respiratoire aiguë Service: Maladies virales Virale ziekten ...
Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions.
Publication Type: Peer reviewed scientific article Authors: Meyer Sauteur, Patrick M; Beeton, Michael L; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycoplasma and Chlamydia Infections (ESGMAC), and the ESGMA ...
Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022.
Publication Type: Peer reviewed scientific article Authors: Meslé, Margaux M I; Sinnathamby, Mary; Mook, Piers; WHO European Region Respiratory Network Group; Pebody, Richard; Lakhani, Anissa; Zambon, Maria; Popovici, Odette; Lazar, Mihaela; Ljubović, Ame ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
Vaccines Europe Hospitalization Humans Pneumonia RNA, Messenger SARS-CoV-2 Vaccine Efficacy Abstract: IntroductionThe I- MOVE- COVID-19 and VEBIS hospital networks have been measuring COVID-19 vaccine ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
study teams (in addition to the named authors) Source: Euro Surveill, Volume 28, Issue 47 (2023) Keywords: Adult BNT162 Vaccine COVID-19 Europe Hospitalization Humans RNA, Viral SARS-CoV-2 Vaccine ...
Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions
Publication Type: Peer reviewed scientific article Authors: Meyer Sauteur, Patrick M; Beeton, Michael L; Pereyre, Sabine; Bébéar, Cécile; Gardette, Marie; Hénin, Nadège; Wagner, Noémie; Fischer, Adrien; Vitale, Alessandra; Lemaire, Baptiste; Greub, Gilber ...
Effect of neuraminidase inhibitor (oseltamivir) treatment on outcome of hospitalised influenza patients, surveillance data from 11 EU countries, 2010 to 2020.
sex, outcome, ward, vaccination status, timing of antiviral treatment, and hospitalisation were obtained. A mixed effect logistic regression model using country as random intercept was applied to ...
Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it?
Publication Type: Peer reviewed scientific article Authors: Patrick M Meyer Sauteur; Victoria J Chalker; Berger, Christoph; Nir-Paz, Ran; Michael L Beeton; ESGMAC and the ESGMAC–MyCOVID study group Source: Lancet Microbe, Volume 3, Issue 12 (2022) Keyword ...
Monitoring of human coronaviruses in Belgian primary care and hospitals, 2015-20: a surveillance study.
care and in possible future vaccination strategies, and co-infections in children younger than 5 years should be considered during diagnosis and treatment. Our findings support the use of national ...
Evaluation of the added value of viral genomic information for predicting severity of influenza infection
Publication Type: Peer reviewed scientific article Authors: Nina Van Goethem; Annie Robert; Nathalie Bossuyt; Laura Van Poelvoorde; Sophie Quoilin; Sigrid C.J. De Keersmaecker; Brecht Devleesschauwer; Isabelle Thomas; Kevin Vanneste; Nancy Roosens; Herman ...